Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Global Health (CD4 and COVID-19) and Health and Nutrition products.
Omega Diagnostics Gp (ODX.L) Speculation regarding a potential fundraise
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Global Health (CD4 and COVID-19) and Health and Nutrition products.
Omega Diagnostics Gp (ODX.L) Directorate Change
Omega (AIM: ODX), the medical diagnostics company focused on Global Health (CD4 and COVID-19) and Health and Nutrition, announces that Colin King, Chief Executive Officer, has notified the Board that
Omega Diagnostics Gp (ODX.L) Confirmation of detection of Omicron variant
VISITECT® COVID-19 antigen test performs with the same high accuracy on the Omicron variant
Omega Diagnostics Gp (ODX.L) DHSC contract update
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Global Health (CD4 and COVID-19) and Health and Nutrition products, provides an update in relation to the Company’s contract
Omega Diagnostics is confident that it can stem losses as the sales momentum increases
Omega Diagnostics, a medical testing company, has reported greater interim losses despite an increase in revenues.
Omega Diagnostics Gp (ODX.L) Half-year Report
INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2021
Omega Diagnostics Gp (ODX.L) Notice of Results and Investor Presentation
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Global Health (CD4 and COVID-19) and Health and Nutrition products, announces it will release its interim results for the
Omega Diagnostics Gp (ODX.L) Update on CTDA Regulations
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Global Health (CD4 and COVID-19) and Health and Nutrition products, notes the UK Health Security Agency’s Medical Devices (Coronavirus
Omega Diagnostics Gp (ODX.L) Partnership with DAM Health and initial LFT order
Agreement for Omega’s Market Leading, UK Manufactured VISITECT ® COVID-19 Antigen LFT
Omega Diagnostics Gp (ODX.L) AGM Statement
Omega (AIM: ODX), the medical diagnostics company focused on Global Health (CD4 and COVID-19) and Health and Nutrition, will hold its Annual General Meeting (‘AGM’) today at 11am at Omega